Clinical Trials Logo

Aging clinical trials

View clinical trials related to Aging.

Filter by:
  • Not yet recruiting  
  • Page 1 ·  Next »

NCT ID: NCT06459310 Not yet recruiting - Aging Clinical Trials

Pilot Study on Evaluating the Geroprotective Effect of Metformin

AGE-M
Start date: June 30, 2024
Phase: Phase 2
Study type: Interventional

The objective of this research is to assess the efficacy of oral metformin in mitigating the aging process in middle-aged and elderly males, to pinpoint sensitive indicators of human senescence, and to offer innovative frameworks and scientific insights for pharmaceutical interventions in aging.

NCT ID: NCT06454942 Not yet recruiting - Aging Clinical Trials

Impact of Regular Consumption of Eggs and Nutrients Fortified Eggs on Eczema Condition in Singapore Individuals

Start date: June 2024
Phase: N/A
Study type: Interventional

The study aims to assess the effects of daily consumption of nutrients-fortified eggs on eczema condition in Singapore individuals with eczema. The investigators hypothesize that egg consumption will improve eczema condition and nutrients fortified egg consumption will improve further improvements when compared to standard egg consumption in individuals with eczema

NCT ID: NCT06444594 Not yet recruiting - Aging Clinical Trials

Transient Receptor Potential Channels

TRP
Start date: June 15, 2024
Phase: Early Phase 1
Study type: Interventional

Neurovascular signaling in the skin associated with stimulation of the transient receptor potential (TRP) channels. These channels are stimulated by both temperature and naturally occurring bioactive agents found in mint, chili peppers, garlic, etc. The aim of the study is to examine how topically applied TRP channel agonists including menthol, capsaicin and camphor impact neurovascular responses in the skin.

NCT ID: NCT06433427 Not yet recruiting - Aging Clinical Trials

Metabolic Dysregulation as Biomarker of Frailty: Role of the Mitochondrial Dysfunction

FRAMITO
Start date: May 29, 2024
Phase:
Study type: Observational [Patient Registry]

The goal of this observational study is to evaluate the presence of mitochondrial dysfunction related to oxidative stress and its possible role in frailty, with and without multimorbidity, and to identify possible frailty biomarkers correlated with mitochondrial dysfunction. The main questions it aims to answer are: - What is the role of oxidative stress-related mitochondrial dysfunction in frailty, taking into account the interaction with multimorbidity. - What could be the specific biomarkers associated with mitochondrial dysfunction in the assessment of frailty. In order to reach the study goals, we will enroll three categories of older adults: - Non-Frail without Multimorbidity (NFWoM); - Frail with Multimorbidity (FWM); - Frail without Multimorbidity (FWoM). Each individual will undergo an assessment of frailty phenotype and multimorbidity, and the collection of blood samples to isolate Peripheral Blood Mononuclear Cells (PBMCs). The identification of frailty biomarkers in each group of participants will be performed by combining untargeted metabolomics-based approaches and functional studies on specific mitochondrial dysfunctions performed on PBMCs and their subpopulations. Multivariate statistical and machine learning techniques will characterize the three clinical phenotype groups based on molecular data.

NCT ID: NCT06432491 Not yet recruiting - Aging Clinical Trials

The Association Between Core Temperature and Health

Start date: June 6, 2024
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to learn if cold water drinking could promote body composition and further extend healthy lifespan in Chinese older adults. The main questions it aims to answer are: 1. Does cold water drinking lower the body fat percentage? 2. Will cold water drinking positively extend lifespan in a long-term Researchers will compare cold water intervention group to a control group (drinking 37℃ water instead) to see if cold water drinking works to promote health and slow down ageing process. Participants will: 1. Drink 4℃ or 37℃ water 4 times (9a.m., 12p.m., 15p.m., 18p.m.) every day for 6 months. 2. Visit the institute and health checkup department for tests and checkup at baseline, the end of the 3rd month, and the end of 6th month.

NCT ID: NCT06430073 Not yet recruiting - Aging Clinical Trials

Effect of Infections and Global DNA Methylation on Frailty Trajectories in Hospitalized Older Patients (INFRAGEN)

INFRAGEN
Start date: May 20, 2024
Phase:
Study type: Observational

This prospective multicenter study aims at exploring the impact of infections on intra-hospital and 3-month changes in the frailty profile of older inpatients. To understand the complex pathways under the relationship between infections and frailty, this study will evaluate infection-related clinical and biochemical markers of systemic inflammation and genetics/epigenetics markers at ward admission. The interplay between clinical, functional, and genetics/epigenetics factors will be evaluated in a subgroup of patients by testing whether 3-month changes in frailty concur with changes in the genomic DNA markers. This study will help characterize the pathophysiological mechanisms of frailty and identify at-risk conditions that may accelerate its course.

NCT ID: NCT06425510 Not yet recruiting - Aging Clinical Trials

Using Technology to Improve Function for Older Latinos With Disabilities in Underserved Areas

Start date: February 1, 2025
Phase: N/A
Study type: Interventional

This project aims to test a culturally appropriate assistive technology (AT) intervention called VIVE-AT to help older Latinos with disabilities improve their function and quality of life. The researchers will first refine the VIVE-AT program based on feedback from a Community Advisory Board and focus groups with older Latinos with disabilities. Then, 76 older Latinos with disabilities will be recruited from a primary care clinic serving low-income communities in Puerto Rico. They will be randomly assigned to either receive the VIVE-AT intervention in the primary care clinic or be placed on a waitlist with regular phone calls. All participants will continue to receive standard care at the clinic.

NCT ID: NCT06417177 Not yet recruiting - Aging Clinical Trials

Impact of Early Aging and Menopause on the Vascular Responses to Hypoxia

Start date: June 2024
Phase: Early Phase 1
Study type: Interventional

The purpose of this study is to examine hypoxic vasodilation and the role of beta-adrenergic receptors in younger premenopausal, perimenopausal, and older postmenopausal women.

NCT ID: NCT06410807 Not yet recruiting - Aging Clinical Trials

Development of Web-Based Mind-Body Trainings for Adults With Subjective Concerns

iMBT
Start date: August 2024
Phase:
Study type: Observational

The goal of this observational study is to develop online, self-paced mindfulness (iMBSR) and lifestyle education (iLifeEd) programs for adults with cognitive concerns. Participants will engage in focus groups to discuss healthy living, web-based behavioral interventions, intervention content/format and ideal outcomes after engaging in behavioral interventions that promote healthy living. Additionally, participants will provide feedback on the protocol and online platform for either iMBSR or iLifeEd. This feedback will be used to refine the iMBSR and iLifeEd protocols for future use in the randomized controlled trial portion of the parent project.

NCT ID: NCT06399809 Not yet recruiting - Aging Clinical Trials

Fisetin to Reduce Senescence and Mobility Impairment in PAD

FIRST
Start date: June 1, 2024
Phase: Phase 2
Study type: Interventional

The investigators propose a pilot randomized trial to gather preliminary data to test the hypothesis that Fisetin will reduce abundance of senescent cells in blood, skeletal muscle, and both subcutaneous and inter muscular adipose tissue and improve 6-minute walk distance in 34 people with PAD. the investigators will determine whether greater declines in abundance of cells with senescent markers are associated with greater improvement in 6-minute walk distance in people with PAD. In exploratory analyses, the investigators will assess whether Fisetin reduces SASP and novel senescent markers in adipose tissue, muscle, and/or blood.